Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
metoprolol succinate + nebivolol (East Coast Institute for Research)
- Development stage
- Unknown
- Lead developer
- East Coast Institute for Research
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Metoprolol succinate + nebivolol refers to a comparative treatment regimen evaluated by the East Coast Institute for Research for the management of hypertension, specifically focusing on its impact on female sexual function. Metoprolol succinate is a cardioselective beta-1 adrenergic receptor antagonist that reduces heart rate and cardiac output. Nebivolol is a third-generation, highly selective beta-1 blocker that uniquely stimulates the endothelial nitric oxide synthase (eNOS) pathway, leading to vasodilation and reduced peripheral resistance. The evaluation of these two agents in a clinical trial context was designed to assess whether nebivolol's vasodilatory properties offer a superior side-effect profile regarding sexual dysfunction compared to traditional beta-blockers like metoprolol succinate in post-menopausal women.
- Other names
- nebivolol and metoprolol succinatemetoprolol succinate and nebivolol
02
Targets
ADRB1 (β1)ADRB2 (β2)ADRB3 (β3)NOS3 (eNOS)
Beyond the preview
Go deeper on metoprolol succinate + nebivolol (East Coast Institute for Research).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on metoprolol succinate + nebivolol (East Coast Institute for Research).